PubMed for id: 4651

Year	Number of Results
1996	1
1998	1
1999	1
2000	1
2001	1
2002	2
2003	2
2004	5
2005	2
2006	4
2007	1
2008	5
2009	3
2010	6
2011	3
2012	2
2013	8
2014	5
2015	8
2016	1
2017	3
2018	5
2019	4
2020	5
2021	5
2022	8
2023	4
2024	0

1

MYO10 regulates genome stability and cancer inflammation through mediating mitosis.

Mayca Pozo F, Geng X, Miyagi M, Amin AL, Huang AY, Zhang Y. Mayca Pozo F, et al. Cell Rep. 2023 May 30;42(5):112531. doi: 10.1016/j.celrep.2023.112531. Epub 2023 May 17. Cell Rep. 2023. PMID: 37200188 Free PMC article.

2

MYO10-filopodia support basement membranes at pre-invasive tumor boundaries.

Peuhu E, Jacquemet G, Scheele CLGJ, Isomursu A, Laisne MC, Koskinen LM, Paatero I, Thol K, Georgiadou M, Guzmán C, Koskinen S, Laiho A, Elo LL, Boström P, Hartiala P, van Rheenen J, Ivaska J. Peuhu E, et al. Dev Cell. 2022 Oct 24;57(20):2350-2364.e7. doi: 10.1016/j.devcel.2022.09.016. Dev Cell. 2022. PMID: 36283390 Free article.

3

MYO10 contributes to the malignant phenotypes of colorectal cancer via RACK1 by activating integrin/Src/FAK signaling.

Ou H, Wang L, Xi Z, Shen H, Jiang Y, Zhou F, Liu Y, Zhou Y. Ou H, et al. Cancer Sci. 2022 Nov;113(11):3838-3851. doi: 10.1111/cas.15519. Epub 2022 Aug 26. Cancer Sci. 2022. PMID: 35912545 Free PMC article.

4

Myosin-X and talin modulate integrin activity at filopodia tips.

Miihkinen M, Grönloh MLB, Popović A, Vihinen H, Jokitalo E, Goult BT, Ivaska J, Jacquemet G. Miihkinen M, et al. Cell Rep. 2021 Sep 14;36(11):109716. doi: 10.1016/j.celrep.2021.109716. Cell Rep. 2021. PMID: 34525374 Free PMC article.

5

Elevated MYO10 Predicts Poor Prognosis and its Deletion Hampers Proliferation and Migration Potentials of Cells Through Rewiring PI3K/Akt Signaling in Cervical Cancer.

He JH, Chen JG, Zhang B, Chen J, You KL, Hu JM, Xu JW, Chen L. He JH, et al. Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820936773. doi: 10.1177/1533033820936773. Technol Cancer Res Treat. 2020. PMID: 32618228 Free PMC article.

6

CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.

Chen J, Liu G, Wu Y, Ma J, Wu H, Xie Z, Chen S, Yang Y, Wang S, Shen P, Fang Y, Fan S, Shen S, Fang X. Chen J, et al. Mol Cancer. 2019 Oct 29;18(1):150. doi: 10.1186/s12943-019-1076-1. Mol Cancer. 2019. PMID: 31665067 Free PMC article.

7

Expression ratio of the TGFβ-inducible gene MYO10 is prognostic for overall survival of squamous cell lung cancer patients and predicts chemotherapy response.

Dvornikov D, Schneider MA, Ohse S, Szczygieł M, Titkova I, Rosenblatt M, Muley T, Warth A, Herth FJ, Dienemann H, Thomas M, Timmer J, Schilling M, Busch H, Boerries M, Meister M, Klingmüller U. Dvornikov D, et al. Sci Rep. 2018 Jun 22;8(1):9517. doi: 10.1038/s41598-018-27912-1. Sci Rep. 2018. PMID: 29934580 Free PMC article.

8

Direct Microtubule-Binding by Myosin-10 Orients Centrosomes toward Retraction Fibers and Subcortical Actin Clouds.

Kwon M, Bagonis M, Danuser G, Pellman D. Kwon M, et al. Dev Cell. 2015 Aug 10;34(3):323-37. doi: 10.1016/j.devcel.2015.06.013. Epub 2015 Jul 30. Dev Cell. 2015. PMID: 26235048 Free PMC article.

9

Myosin-X and disease.

Courson DS, Cheney RE. Courson DS, et al. Exp Cell Res. 2015 May 15;334(1):10-5. doi: 10.1016/j.yexcr.2015.03.014. Epub 2015 Mar 27. Exp Cell Res. 2015. PMID: 25819274 Free PMC article. Review.

10

NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10.

Sun Y, Ai X, Shen S, Lu S. Sun Y, et al. Oncotarget. 2015 Apr 10;6(10):8244-54. doi: 10.18632/oncotarget.3135. Oncotarget. 2015. PMID: 25749519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year